500124:BOM
Dr Reddy's Laboratories Ltd
1Â 231,85Â INR
arrow_upward
+0,91%(+11,10) 1 d
16 okt., 15:59:49 GMT+5:30 · INR
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för 500124 …
Öppen
1Â 227,10Â INR
Högt
1Â 231,85Â INR
LÃ¥gt
1Â 213,80Â INR
Börsvärde
1,02Â bn
Genomsn. vol.
87,44Â tn
Volym
77,54Â tn
Utdelning
0,65Â %
Kvartalsvis utdelning
2,00Â INR
Ex-utdelningsdatum
10 juli 2026
P/E-tal
31,85
52v högst
1Â 414,40Â INR
52v lägst
1Â 080,05Â INR
EPS
38,67Â INR
Utestående aktier
166,06Â mn
Antal anställda
28Â tn
Öppen
1Â 227,10Â INR
Högt
1Â 231,85Â INR
LÃ¥gt
1Â 213,80Â INR
Börsvärde
1,02Â bn
Genomsn. vol.
87,44Â tn
Volym
77,54Â tn
Utdelning
0,65Â %
Kvartalsvis utdelning
2,00Â INR
Ex-utdelningsdatum
10 juli 2026
P/E-tal
31,85
52v högst
1Â 414,40Â INR
52v lägst
1Â 080,05Â INR
EPS
38,67Â INR
Utestående aktier
166,06Â mn
Antal anställda
28Â tn
Nyheter och artiklar
Från webbkällor och nyhetspartner
HurBra.se
·
för 2 dagar sedan
USA-börsen 15 oktober 2026: Vård lyfte, AI pressades
AskTraders.com
·
för 55 minuter sedan
S&P 500 Can Absorb Fed Hikes, Says UBS CIO After Hot US Inflation
Traders Union
·
för 1 timme sedan
Peter Tuchman: Nasdaq posts worst week since April 2025 tariff selloff as S&P 500 loses $1.3 trillion
Yahoo Finance
·
för 10 timmar sedan
Michael Burry Warns of a Stock Market ‘Supervolcano’
Profil
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Om Dr Reddy's Laboratories Ltd
VdErez Israeli
Anställda27,5 tn
Grundades1984
HuvudkontorHyderabad, Andhra Pradesh, Indien
Sektor-
Webbplatsdrreddys.com